{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:55:14Z","timestamp":1792803314137,"version":"4.5.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2007,7,20]],"date-time":"2007-07-20T00:00:00Z","timestamp":1184889600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2007,8,8]]},"DOI":"10.1007\/s00296-007-0413-7","type":"journal-article","created":{"date-parts":[[2007,7,18]],"date-time":"2007-07-18T23:52:01Z","timestamp":1184802721000},"page":"1031-1039","source":"Crossref","is-referenced-by-count":37,"title":["Is there a predisposition for the development of autoimmune diseases in patients with fibromyalgia? Retrospective analysis with long term follow-up"],"prefix":"10.1007","volume":"27","author":[{"given":"Ina","family":"K\u00f6tter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Neuscheler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilhan","family":"G\u00fcnaydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothee","family":"Wernet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhild","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,7,20]]},"reference":[{"key":"413_CR1","unstructured":"1990 classification criteria of fibromyalgia from the American College of Rheumatology. Report of the multicenter criteria committee. Union Med Can 1990 119:272"},{"key":"413_CR2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/07853899708998739","volume":"29","author":"DJ Wallace","year":"1997","unstructured":"Wallace DJ (1997) The fibromyalgia syndrome. Ann Med 29:9\u201321","journal-title":"Ann Med"},{"key":"413_CR3","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archinte.159.8.777","volume":"159","author":"DL Goldenberg","year":"1999","unstructured":"Goldenberg DL (1999) Fibromyalgia syndrome a decade later: what have we learned? Arch Intern Med 159:777\u2013785","journal-title":"Arch Intern Med"},{"key":"413_CR4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/rheumatology\/32.2.139","volume":"32","author":"J Ledingham","year":"1993","unstructured":"Ledingham J, Doherty S, Doherty M (1993) Primary fibromyalgia syndrome\u2013an outcome study. Br J Rheumatol 32:139\u201342","journal-title":"Br J Rheumatol"},{"key":"413_CR5","first-page":"1580","volume":"21","author":"AS Russell","year":"1994","unstructured":"Russell AS, Percy JS (1994) Disabling fibromyalgia: appearance vs reality. J Rheumatol 21:1580","journal-title":"J Rheumatol"},{"key":"413_CR6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0049-0172(95)80006-9","volume":"24","author":"KP White","year":"1995","unstructured":"White KP, Harth M, Teasell RW (1995) Work disability evaluation and the fibromyalgia syndrome. Semin Arthritis Rheum 24:371\u2013381","journal-title":"Semin Arthritis Rheum"},{"key":"413_CR7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3109\/03009749509099295","volume":"24","author":"F Wolfe","year":"1995","unstructured":"Wolfe F, Aarflot T, Bruusgaard D, et al (1995) Fibromyalgia and disability. Report of the Moss international working group on medico-legal aspects of chronic widespread musculoskeletal pain complaints and fibromyalgia. Scand J Rheumatol 24:112\u2013118","journal-title":"Scand J Rheumatol"},{"key":"413_CR8","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/art.1780391004","volume":"39","author":"RM Bennett","year":"1996","unstructured":"Bennett RM (1996) Fibromyalgia and the disability dilemma. A new era in understanding a complex, multidimensional pain syndrome. Arthritis Rheum 39:1627\u20131634","journal-title":"Arthritis Rheum"},{"key":"413_CR9","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0002-9343(96)00234-3","volume":"101","author":"D Buchwald","year":"1996","unstructured":"Buchwald D, Pearlman T, Umali J, Schmaling K, Katon W (1996) Functional status in patients with chronic fatigue syndrome, other fatiguing illnesses, and healthy individuals. Am J Med 101:364\u201370","journal-title":"Am J Med"},{"key":"413_CR10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0889-857X(05)70277-5","volume":"22","author":"F Wolfe","year":"1996","unstructured":"Wolfe F, Potter J (1996) Fibromyalgia and work disability: is Fibromyalgia a disabling disorder? Rheum Dis Clin North Am 22:369\u2013391","journal-title":"Rheum Dis Clin North Am"},{"key":"413_CR11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1477-5751-2-4","volume":"2","author":"V Noller","year":"2003","unstructured":"Noller V, Sprott H (2003) Prospective epidemiological observations on the course of the disease in fibromyalgia patients. J Negat Results Biomed 2:4","journal-title":"J Negat Results Biomed"},{"key":"413_CR12","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0950-3579(05)80051-2","volume":"8","author":"JI Hudson","year":"1994","unstructured":"Hudson JI, Pope HG (1994) The concept of affective spectrum disorder: relationship to fibromyalgia and other syndromes of chronic fatigue and chronic muscle pain. Baillieres Clin Rheumatol 8:839\u2013856","journal-title":"Baillieres Clin Rheumatol"},{"key":"413_CR13","first-page":"19","volume":"55","author":"R Dohrenbusch","year":"1996","unstructured":"Dohrenbusch R, Gruterich M, Genth E (1996) Fibromyalgia and Sjogren syndrome\u2013clinical and methodological aspects. Z Rheumatol 55:19\u201327","journal-title":"Z Rheumatol"},{"key":"413_CR14","first-page":"71","volume":"15","author":"M Tishler","year":"1997","unstructured":"Tishler M, Barak Y, Paran D, Yaron M (1997) Sleep disturbances, fibromyalgia and primary Sjogren\u2019s syndrome. Clin Exp Rheumatol 15:71\u201374","journal-title":"Clin Exp Rheumatol"},{"key":"413_CR15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/096120339400300310","volume":"3","author":"EF Morand","year":"1994","unstructured":"Morand EF, Miller MH, Whittingham S, Littlejohn GO (1994) Fibromyalgia syndrome and disease activity in systemic lupus erythematosus. Lupus 3:187\u2013191","journal-title":"Lupus"},{"key":"413_CR16","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/art.1780370812","volume":"37","author":"GD Middleton","year":"1994","unstructured":"Middleton GD, McFarlin JE, Lipsky PE (1994) The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus. Arthritis Rheum 37:1181\u20131188","journal-title":"Arthritis Rheum"},{"key":"413_CR17","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s100670200118","volume":"21","author":"AW Al-Allaf","year":"2002","unstructured":"Al-Allaf AW, Ottewell L, Pullar T (2002) The prevalence and significance of positive antinuclear antibodies in patients with fibromyalgia syndrome: 2\u20134\u00a0years\u2019 follow-up. Clin Rheumatol 21:472\u2013477","journal-title":"Clin Rheumatol"},{"key":"413_CR18","first-page":"368","volume":"13","author":"H Dinerman","year":"1986","unstructured":"Dinerman H, Goldenberg DL, Felson DT (1986) A prospective evaluation of 118 patients with the fibromyalgia syndrome: prevalence of Raynaud\u2019s phenomenon, sicca symptoms, ANA, low complement, and Ig deposition at the dermal-epidermal junction. J Rheumatol 13:368\u2013373","journal-title":"J Rheumatol"},{"key":"413_CR19","first-page":"696","volume":"11","author":"AJ Bridges","year":"1993","unstructured":"Bridges AJ (1993) Fibromyalgia, antinuclear antibodies and clinical features of connective tissue disease. Clin Exp Rheumatol 11:696\u2013697","journal-title":"Clin Exp Rheumatol"},{"key":"413_CR20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00124743-199810000-00016","volume":"4","author":"DA McLain","year":"1998","unstructured":"McLain DA (1998) Clinical features of ANA-positive and ANA-negative patients with fibromyalgia. J Clin Rheumatol 4:292\u2013293","journal-title":"J Clin Rheumatol"},{"key":"413_CR21","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/art.1780381014","volume":"38","author":"J Calvo-Alen","year":"1995","unstructured":"Calvo-Alen J, Bastian HM, Straaton KV, Burgard SL, Mikhail IS, Alarcon GS (1995) Identification of patient subsets among those presumptively diagnosed with, referred, and\/or followed up for systemic lupus erythematosus at a large tertiary care center. Arthritis Rheum 38:1475\u20131484","journal-title":"Arthritis Rheum"},{"key":"413_CR22","unstructured":"Ritts RE, Mackay IR (1979) WHO handbook of immunological tecjniques: World Health Organisation"},{"key":"413_CR23","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4049\/jimmunol.96.3.464","volume":"96","author":"EM Tan","year":"1966","unstructured":"Tan EM, Kunkel HG (1966) Characteristics of a soluble nuclear antigen preparation with sera of patients with systemic lupus erythematosus. J Immunol 96:464","journal-title":"J Immunol"},{"key":"413_CR24","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen H, Fries JF et al (1982) The 1982 Revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271\u20131277","journal-title":"Arthritis Rheum"},{"key":"413_CR25","first-page":"1557","volume":"20","author":"MB Yunus","year":"1993","unstructured":"Yunus MB, Hussey FX, Aldag JC (1993) Antinuclear antibodies and connective tissue disease features in fibromyalgia syndrome: a controlled study. J Rheumatol 20:1557\u20131560","journal-title":"J Rheumatol"},{"key":"413_CR26","first-page":"1682","volume":"17","author":"A Bengtsson","year":"1990","unstructured":"Bengtsson A, Ernerudh J, Vrethem M, Skogh T (1990) Absence of autoantibodies in primary fibromyalgia. J Rheumatol 17:1682\u20131683","journal-title":"J Rheumatol"},{"key":"413_CR27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/978-3-642-85226-8_33","volume":"210","author":"S Silverman","year":"1996","unstructured":"Silverman S, Gluck O, Silver D et al (1996) The prevalence of autoantibodies in symptomatic and asymptomatic patients with breast implants and patients with fibromyalgia. Curr Top Microbiol Immunol 210:317\u2013322","journal-title":"Curr Top Microbiol Immunol"},{"key":"413_CR28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-3-642-85226-8_28","volume":"210","author":"AJ Bridges","year":"1996","unstructured":"Bridges AJ, Anderson JD, Burns DE, Kemple K, Kaplan JD, Lorden T (1996) Autoantibodies in patients with silicone implants. Curr Top Microbiol Immunol 210:277\u2013282","journal-title":"Curr Top Microbiol Immunol"},{"key":"413_CR29","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/BF00207485","volume":"72","author":"R Klein","year":"1994","unstructured":"Klein R, Berg PA (1994) A comparative study on antibodies to nucleoli and 5-hydroxytryptamine in patients with fibromyalgia syndrome and tryptophan-induced eosinophilia-myalgia syndrome. Clin Investig 72:541\u2013549","journal-title":"Clin Investig"},{"key":"413_CR30","first-page":"137","volume":"12","author":"J Forslid","year":"1994","unstructured":"Forslid J, Heigl Z, Jonsson J, Scheynius A (1994) The prevalence of antinuclear antibodies in healthy young persons and adults, comparing rat liver tissue sections with Hep-2 cells as antigen substrate. Clin Exp Rheumatol 12:137\u2013141","journal-title":"Clin Exp Rheumatol"},{"key":"413_CR31","first-page":"1529","volume":"18","author":"M Petri","year":"1991","unstructured":"Petri M, Karlson EW, Cooper DS, Ladenson PW (1991) Autoantibody tests in autoimmune thyroid disease: a case-control study. J Rheumatol 18:1529\u20131531","journal-title":"J Rheumatol"},{"key":"413_CR32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0190-9622(00)90121-X","volume":"42","author":"DF Mutasim","year":"2000","unstructured":"Mutasim DF, Adams BB (2000) A practical guide for serologic evaluation of autoimmune connective tissue diseases. J Am Acad Dermatol 42:159\u2013174","journal-title":"J Am Acad Dermatol"},{"key":"413_CR33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5858\/2000-124-0071-GFCUOT","volume":"124","author":"AF Kavanaugh","year":"2000","unstructured":"Kavanaugh AF, Tomar R, Reveille JD, Solomon DH, Homburger HA (2000) Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. Arch Pathol Lab Med 124:71\u201381","journal-title":"Arch Pathol Lab Med"},{"key":"413_CR34","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1093\/clinchem\/47.9.1649","volume":"47","author":"N Hayashi","year":"2001","unstructured":"Hayashi N, Kawamoto T, Mukai M et al (2001) Detection of antinuclear antibodies by use of an enzyme immunoassay with nuclear Hep-2 cell extract and recombinant antigens: comparison with immunofluorescence assay in 307 patients. Clin Chem 47:1649\u20131659","journal-title":"Clin Chem"},{"key":"413_CR35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0047-6374(79)90021-6","volume":"10","author":"JP Pandey","year":"1979","unstructured":"Pandey JP, Fudenberg HH, Ainsworth SK, Loadholt CB (1979) Autoantibodies in healthy subjects of different age groups. Mech Ageing Dev 10:399\u2013404","journal-title":"Mech Ageing Dev"},{"key":"413_CR36","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/art.1780400909","volume":"40","author":"EM Tan","year":"1997","unstructured":"Tan EM, Feltkamp TE, Smolen J, Butcher B, Dawkins R, Fritzler MJ (1997) Range of antinuclear antibodies in \u201chealthy\u201d individuals. Arthritis Rheum 40:1601\u20131611","journal-title":"Arthritis Rheum"},{"key":"413_CR37","first-page":"433","volume":"18","author":"JH Vaile","year":"2000","unstructured":"Vaile JH, Dyke L, Kherani R, Johnston C, Higgins T, Russell AS (2000) Is high titre ANA specific for connective tissue disease? Clin Exp Rheumatol 18:433\u2013438","journal-title":"Clin Exp Rheumatol"},{"key":"413_CR38","first-page":"393","volume":"11","author":"K Vlam De","year":"1993","unstructured":"De Vlam K, De Keyser F, Verbruggen G, et al (1993) Detection and identification of antinuclear autoantibodies in the serum of normal blood donors. Clin Exp Rheumatol 11:393\u2013397","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"413_CR39","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0090-1229(85)90045-5","volume":"36","author":"MJ Fritzler","year":"1985","unstructured":"Fritzler MJ, Pauls JD, Kinsella TD, Bowen TJ (1985) Antinuclear, anticytoplasmatic, and anti-Sjogren\u2019s syndrome antigen A (SS-A\/Ro) antibodies in female blood donors. Clin Immunol Immunopathol 36(1):120\u2013128","journal-title":"Clin Immunol Immunopathol"},{"key":"413_CR40","first-page":"914","volume":"26","author":"WY Craig","year":"1999","unstructured":"Craig WY, Ledue TB, Johnson AM, Ritchie RF (1999) The distribution of antinuclear antibody titres in \u201cnormal\u201d children and adults. J Rheumatol 26:914\u2013919","journal-title":"J Rheumatol"},{"key":"413_CR41","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S0140-6736(84)92547-9","volume":"1","author":"R Moulias","year":"1984","unstructured":"Moulias R, Proust J, Wang A et al (1984) Age-related increase in autoantibodies. Lancet 1:1128\u20131129","journal-title":"Lancet"},{"key":"413_CR42","first-page":"1919","volume":"19","author":"M Vrethem","year":"1992","unstructured":"Vrethem M, Skogh T, Berlin G, Ernerudh J (1992) Autoantibodies versus clinical symptoms in blood donors. J Rheumatol 19:1919\u20131921","journal-title":"J Rheumatol"},{"key":"413_CR43","first-page":"S274","volume":"39","author":"HM Bastian","year":"1996","unstructured":"Bastian HM, Amos M, Mikhail IS (1996) Serological characterisation of patients with ANA-positive fibromyalgia-manifestations using autoantibody ELISA. Arthritis Rheum 39:S274","journal-title":"Arthritis Rheum"},{"key":"413_CR44","first-page":"2239","volume":"21","author":"BAE Walz Le Blanc","year":"1994","unstructured":"Walz Le Blanc BAE, Gladman DD, Urowitz MB (1994) Serologically active clinically quiescent systemic lupus erythematosus: predictors of clinical flares. J Rheumatol 21:2239\u20132241","journal-title":"J Rheumatol"},{"key":"413_CR45","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00002281-199509000-00006","volume":"7","author":"M Petri","year":"1995","unstructured":"Petri M (1995) Clinical features of systemic lupus erythematosus. Curr Opin Rheumatol 7:395\u2013401","journal-title":"Curr Opin Rheumatol"},{"key":"413_CR46","first-page":"1377","volume":"19","author":"K Aho","year":"1992","unstructured":"Aho K, Koskela P, M\u00e4kitalo R, Heliovaara M, Palosuo T (1992) Antinuclear antibodies heralding the onset of systemic lupus erythematosus. J Rheumatol 19:1377\u20131379","journal-title":"J Rheumatol"},{"key":"413_CR47","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00002060-199705000-00014","volume":"76","author":"PA Smart","year":"1997","unstructured":"Smart PA, Waylonis GW, Hackshaw KV (1997) Immunologic profile of patients with fibromyalgia. Am J Phys Med Rehabil 76:231\u2013234","journal-title":"Am J Phys Med Rehabil"},{"key":"413_CR48","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/03009749950155751","volume":"28","author":"S Dijkstra","year":"1999","unstructured":"Dijkstra S, Nieuwenhuis EJ, Swaak AJG (1999) The prognosis and outcome of patients referred to an outpatient clinic for rheumatic diseases characterised by the presence of antinuclear antibodies (ANA). Scand J Rheumatol 28:33\u201337","journal-title":"Scand J Rheumatol"},{"key":"413_CR49","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","volume":"349","author":"M Arbuckle","year":"2003","unstructured":"Arbuckle M, McClain MT, Rubertone MV et al (2003) Development of autoantibodies before the cllinical onset of systemic lupus erythematosus. N Engl J Med 349:1526\u20131533","journal-title":"N Engl J Med"},{"key":"413_CR50","first-page":"886","volume":"25","author":"PG Vlachoyiannopoulos","year":"1998","unstructured":"Vlachoyiannopoulos PG, Tzayara V, Dafni U, Spanos E, Moutsopoulos HM (1998) Clinical features and evolution of antinuclear antibody positive individuals in a rheumatology outpatient clinic. J Rheumatol 25:886\u2013891","journal-title":"J Rheumatol"},{"key":"413_CR51","first-page":"892","volume":"95","author":"PM Deane","year":"1995","unstructured":"Deane PM, Liard G, Siegel DM, Baum J (1995) The outcome of children referred to a pediatric rheumatology clinic with a positive antinuclear antibody test but without an autoimmune disease. Pediatrics 95:892\u2013895","journal-title":"Pediatrics"},{"key":"413_CR52","first-page":"736","volume":"30","author":"SO Myckatyn","year":"2003","unstructured":"Myckatyn SO, Russell AS (2003) Outcome of positive antinuclear antibodies in individuals without connective tissue disease. J Rheumatol 30:736\u2013739","journal-title":"J Rheumatol"},{"key":"413_CR53","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/ard.44.4.245","volume":"44","author":"AJG Swaak","year":"1985","unstructured":"Swaak AJG, Smeenk RJ (1985) Detection of anti-dsDNA as a diagnostic tool: a prospective study in 441 non-systemic lupus erythematosus patients with anti-dsDNA antibody (anti-dsDNA). Ann Rheum Dis 44:245\u2013251","journal-title":"Ann Rheum Dis"},{"key":"413_CR54","first-page":"402","volume":"75","author":"O Yadin","year":"1989","unstructured":"Yadin O, Sarov B, Naggan L, Slor H, Shoenfeld Y (1989) Natural autoantibodies in the serum of healthy women\u2013\u2013a five year follow-up. Clin Exp Immunol 75:402\u2013406","journal-title":"Clin Exp Immunol"},{"key":"413_CR55","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1300\/J094v02n02_06","volume":"2","author":"A Bengtsson","year":"1994","unstructured":"Bengtsson A, Backman E, Lindblom B, Skogh T (1994) Long term follow-up of fibromyalgia patients: clinical symptoms, muscular function, laboratory tests\u2013\u2013an eight year comparison study. J Musculoskelet Pain 2:67\u201380","journal-title":"J Musculoskelet Pain"},{"key":"413_CR56","first-page":"133","volume":"22","author":"RP Bonafede","year":"1995","unstructured":"Bonafede RP, Downey DC, Bennett RM (1995) An association of fibromyalgia with primary Sjogren\u2019s syndrome: a prospective study of 72 patients. J Rheumatol 22:133\u2013136","journal-title":"J Rheumatol"},{"key":"413_CR57","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/03009740252937540","volume":"31","author":"JT Gran","year":"2002","unstructured":"Gran JT (2002) Diagnosis and definition of primary Sjogren\u2019s syndrome. Scand J Rheumatol 31:57\u201359","journal-title":"Scand J Rheumatol"},{"key":"413_CR58","first-page":"938","volume":"29","author":"FB Vivino","year":"2002","unstructured":"Vivino FB, Gala I, Hermann GA (2002) Change in final diagnosis on second evaluation of labial minor salivary gland biopsies. J Rheumatol 29:938\u2013944","journal-title":"J Rheumatol"},{"key":"413_CR59","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjogren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554\u2013556","journal-title":"Ann Rheum Dis"},{"key":"413_CR60","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1385\/CRIAI:25:1:25","volume":"25","author":"D Buskila","year":"2003","unstructured":"Buskila D, Press J, Abu-Shakra M (2003) Fibromyalgia in systemic lupus erythematosus: prevalence and clinical implications. Clin Rev Allergy Immunol 25:25\u201328","journal-title":"Clin Rev Allergy Immunol"},{"key":"413_CR61","doi-asserted-by":"crossref","first-page":"868","DOI":"10.7326\/0003-4819-134-9_Part_2-200105011-00011","volume":"134","author":"LA Aaron","year":"2001","unstructured":"Aaron LA, Buchwald D (2001) A review of the evidence for overlap among unexplained clinical conditions. Ann Intern Med 134:868\u2013881","journal-title":"Ann Intern Med"},{"key":"413_CR62","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/rheumatology\/38.4.355","volume":"38","author":"F Wolfe","year":"1999","unstructured":"Wolfe F (1999) Determinants of WOMAC function, pain and stiffness scores: evidence for the role of low back pain, symptom counts, fatigue and depression in osteoarthritis, rheumatoid arthritis and fibromyalgia. Rheumatology (Oxford) 38:355\u2013361","journal-title":"Rheumatology (Oxford)"},{"key":"413_CR63","first-page":"1407","volume":"23","author":"F Wolfe","year":"1996","unstructured":"Wolfe F, Hawley DJ, Wilson K (1996) The prevalence and meaning of fatigue in rheumatic disease. J Rheumatol 23:1407\u20131417","journal-title":"J Rheumatol"},{"key":"413_CR64","first-page":"818","volume":"21","author":"A Hidding","year":"1994","unstructured":"Hidding A, van Santen M, De Klerk E et al (1994) Comparison between self-report measures and clinical observations of functional disability in ankylosing spondylitis, rheumatoid arthritis and fibromyalgia. J Rheumatol 21:818\u2013823","journal-title":"J Rheumatol"},{"key":"413_CR65","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11916-001-0024-z","volume":"5","author":"M Martinez-Lavin","year":"2001","unstructured":"Martinez-Lavin M (2001) Overlap of fibromyalgia with other medical conditions. Curr Pain Headache Rep 5:347\u2013350","journal-title":"Curr Pain Headache Rep"},{"key":"413_CR66","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1177\/096120339700600603","volume":"6","author":"R Bennett","year":"1997","unstructured":"Bennett R (1997) The concurrence of lupus and fibromyalgia: implications for diagnosis and management. Lupus 6:494\u2013499","journal-title":"Lupus"},{"key":"413_CR67","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3949\/ccjm.64.7.361","volume":"64","author":"GS Alarcon","year":"1997","unstructured":"Alarcon GS (1997) Arthralgias, myalgias, facial erythema, and a positive ANA: not necessarily SLE. Cleve Clin J Med 64:361\u2013364","journal-title":"Cleve Clin J Med"},{"key":"413_CR68","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/00124743-199912000-00006","volume":"5","author":"M Martinez-Lavin","year":"1999","unstructured":"Martinez-Lavin M, Leon A, Pineda C, Amogo MC, Hermosillo AG (1999) The dysautonomia of fibromyalgia may simulate lupus. J Clin Rheumatol 5:332\u2013334","journal-title":"J Clin Rheumatol"},{"key":"413_CR69","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s002960050090","volume":"19","author":"I Gunaydin","year":"1999","unstructured":"Gunaydin I, Terhorst T, Eckstein A, Daikeler T, Kanz L, Kotter I (1999) Assessment of keratoconjunctivitis sicca in patients with fibromyalgia: results of a prospective study. Rheumatol Int 19:7\u20139","journal-title":"Rheumatol Int"},{"key":"413_CR70","first-page":"1841","volume":"30","author":"NL Rhodus","year":"2003","unstructured":"Rhodus NL, Fricton J, Carlson P, Messner R (2003) Oral symptoms associated with fibromyalgia syndrome. J Rheumatol 30:1841\u20131845","journal-title":"J Rheumatol"},{"key":"413_CR71","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/rheumatology\/41.4.416","volume":"41","author":"EJ Price","year":"2002","unstructured":"Price EJ, Venables PJ (2002) Dry eyes and mouth syndrome\u2013a subgroup of patients presenting with sicca symptoms. Rheumatology (Oxford) 41:416\u2013422","journal-title":"Rheumatology (Oxford)"},{"key":"413_CR72","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1111\/j.1572-0241.1999.01146.x","volume":"94","author":"A Barton","year":"1999","unstructured":"Barton A, Pal B, Whorwell PJ, Marshall D (1999) Increased prevalence of sicca complex and fibromyalgia in patients with irritable bowel syndrome. Am J Gastroenterol 94:1898\u20131901","journal-title":"Am J Gastroenterol"},{"key":"413_CR73","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/bmj.324.7332.300","volume":"324","author":"M Wright","year":"2002","unstructured":"Wright M (2002) Widespread body pain and mortality. Diagnosing fibromyalgia stops doctors from thinking. BMJ 324:300","journal-title":"BMJ"},{"key":"413_CR74","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0002-9343(97)00159-9","volume":"103","author":"MA Fitzcharles","year":"1997","unstructured":"Fitzcharles MA, Esdaile JM (1997) The overdiagnosis of fibromyalgia syndrome. Am J Med 103:44\u201350","journal-title":"Am J Med"},{"key":"413_CR75","first-page":"757","volume":"38","author":"T Ohtsuka","year":"1998","unstructured":"Ohtsuka T, Tamura T, Yamakage A, Yamazaki S (1998) The predictive value of quantitative nailfold capillary microscopy in patients with undifferentiated connective tissue disease. Br J Dermatol 38:757\u2013764","journal-title":"Br J Dermatol"},{"key":"413_CR76","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/jcp.53.6.424","volume":"53","author":"W Egner","year":"2000","unstructured":"Egner W (2000) The use of laboratory tests in the diagnosis of SLE. J Clin Pathol 53:424\u2013432","journal-title":"J Clin Pathol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-007-0413-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-007-0413-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-007-0413-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T21:54:42Z","timestamp":1708120482000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-007-0413-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,20]]},"references-count":76,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,8,8]]}},"alternative-id":["413"],"URL":"https:\/\/doi.org\/10.1007\/s00296-007-0413-7","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,20]]}}}